Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Imperial College have published an innovative study in the BCS demonstrating that adverse symptom related to statin, placebo or no treatment. The study design was…View More N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Statement following a Medical Device Alert issued by the MHRAView More Enhanced Follow Up for Patients with Trifecta Aortic Valve Bioprostheses: A Statement from BHVS, SCTS and BCS
Dr Rebecca Dobson addresses the findings from a recent survey on why trainees don’t pursue careers in cardiology.View More Women NOT in cardiology – where are we going wrong?
Meetings and courses to remain online during COVID-19 pandemicView More ESC Congress 2021 to Be Held Online
Day One By Dr Noor Sharrack, Cardiology SpR With public gatherings banned in the Netherlands due to the COVID-19 pandemic, the 2020 edition of the…View More ESC Congress 2020 – The Digital Experience
The purpose of the guideline is to help healthcare professionals who are not cardiology specialists identify and treat acute myocardial injury and its cardiac complications in adults with known or suspected COVID-19 but without known pre-existing cardiovascular disease.View More RAPID GUIDELINE: National Institute for Healthcare and Excellence (NICE)